Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil |
| |
| Authors: | R Sesso J M Eisenberg C Stabile S Draibe H Ajzen O Ramos |
| |
| Affiliation: | Escola Paulista de Medicina, Disciplina de Nefrologia, S?o Paulo, Brazil 04023. |
| |
| Abstract: | Cost-effectiveness analysis compared four treatments of end-stage renal disease in Brazil: continuous ambulatory peritoneal dialysis (CAPD), in-center hemodialysis (HD), cadaver donor transplantation (CD-Tx), and living related donor transplantation (LR-Tx). After 2 years, the costs per year of survival were CAPD, $12,134; HD, $10,065; CD-Tx, $6,978; and LR-Tx, $3,022. The HD cost was lower than CAPD partially because of the reuse of hemodialyzers in Brazil. Although less cost-effective, both dialysis treatments yielded more years of survival after 2 years. This analysis reveals a trade-off between cost per year of survival and years of survival. |
| |
| Keywords: | |
|
|
